Elmas Ogus

Elmas Ogus

Auto-generated profile, based on publicly available information

Elmas Ogus

Clinic of Clinical Biochemistry, Ankara Training and Research Hospital, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Visceral Medicine
Verified
Journal Article
Open access
PDF file
SKSerdar Kuru
Serdar Kuru
KKKemal Kismet
Kemal Kismet
ABAziz M. Barlas
Aziz M. Barlas
STSalih Tuncal
Salih Tuncal
PCPinar Celepli
Pinar Celepli
EEErtugrul Ertas
Ertugrul Ertas
Background: Montelukast is a cysteinyl-leukotriene type 1 (CysLT1) selective receptor antagonist. In recent years, investigations have shown that montelukast possesses secondary anti-inflammatory activities and also antioxidant effects. For this reason, we aimed to determine the possible effects of montelukast on liver damage in experimental obstructive jaundice. Methods: 30 Wistar-Albino male rats were randomized and divided into three groups of 10 animals each: group I, sham-operated; group II, ligation and division of the common bile duct (BDL) followed by daily intraperitoneal injection of 1 ml of saline; group III, BDL followed by daily intraperitoneal injection of 10 mg/kg montelukast dissolved in saline. The animals were killed on postoperative day 7 by high-dose diethyl ether inhalation. Blood and liver samples were taken for examination. Results: In this study, liver malondialdehyde (MDA) (p = 0.001), myeloperoxidase (p = 0.003), and total sulfhydryl (SH) (p = 0.009) were found to be significantly different between the BDL + montelukast and the BDL groups. Plasma total SH (p = 0.002) and MDA (p = 0.027) values were also statistically different between these groups. Statistical analyses of histological activity index scores showed that the histopathological damage in the BDL + montelukast group was significantly less than the damage in the control group (p < 0.05 for all pathological parameters). Conclusion: According to the results of this study, montelukast showed a significant hepatoprotective effect in this experimental obstructive jaundice model, which might be due to its antioxidant and anti-inflammatory activities.

3 February 2025 in Eurasian Journal of Anesthesiology and Intensive Care
Verified
Journal Article
Open access
PDF file
EÇErdi Çelik
Erdi Çelik
SASehbal Arslankoz
Sehbal Arslankoz
PKPınar Koyuncu
Pınar Koyuncu
EÖElmas Öğüş
Elmas Öğüş
RPReyhan Polat
Reyhan Polat
ADAslı Dönmez
Aslı Dönmez
Aims: Sevoflurane is a volatile anesthetic agent commonly used for the induction and maintenance of general anesthesia. Recent case reports and case series have highlighted the analgesic and anti-inflammatory properties of sevoflurane when applied topically to venous ulcers, diabetic wounds, and infected wounds. This study investigates the therapeutic effects of topically applied sevoflurane on thermal burn wounds in rats, focusing on inflammatory responses and wound healing processes. Methods: Twenty-one male Wistar Albino rats underwent the induction of a second-degree thermal burn covering 3 cm² on the interscapular skin. The animals were randomized into three groups: the experimental group (Group S) received 3 ml of topical sevoflurane (1 ml/cm²), the control group (Group I) received 3 ml of isotonic saline, and the sham group (Group K) received no treatment. Plasma concentrations of TNF-?, IL-1ß, IL-6, and IL-10 were measured at baseline, and on days 7 and 14 post-injury. Histopathological evaluations of the burn sites were conducted on day 14, assessing for active and chronic inflammation, granulation, and fibrosis. Results: All rats in the study maintained similar age and weight profiles across the groups. Histologically, the sevoflurane group exhibited significantly reduced chronic inflammation and enhanced granulation and fibrosis compared to controls. Immunologically, IL-6 and IL-10 levels were elevated in the isotonic group but did not differ significantly from baseline in other groups. Plasma cytokine levels were comparable across all groups. Conclusion: Topical sevoflurane appears to promote wound healing by modulating inflammatory responses and enhancing tissue repair processes in a rat burn model. These findings indicate that sevoflurane may serve as a beneficial adjunctive therapy in the management of burn injuries and general wound care. Given its established anti-inflammatory effects when inhaled, there is a compelling need for further research to investigate the potential benefits and mechanisms of topical sevoflurane application. Such studies could provide valuable insights into optimizing wound healing processes and improving patient outcomes.

1 January 2007 in Annals of Saudi Medicine
Verified
Journal Article
Open access
DDDILEK DILLI
DILEK DILLI
IBIlknur Bostanci
Ilknur Bostanci
EOElmas Ogus
Elmas Ogus
SDSeyda Dogankoc
Seyda Dogankoc
ETEgemen Tug
Egemen Tug
YDYildiz Dallar
Yildiz Dallar
How is Magento beating the competition?

7 February 2024 in Galician Medical Journal
Verified
Journal Article
Open access
PDF file
EBEsra Şahingöz Bakırcı
Esra Şahingöz Bakırcı
BNBaris Nacir
Baris Nacir
MAMurat Alisik
Murat Alisik
HGHakan Genc
Hakan Genc
EOElmas Ogus
Elmas Ogus
ÖEÖzcan EREL
Özcan EREL
Aim. We aimed to examine the thiol-disulfide (SS) balance, a recognized marker of oxidative stress, in fibromyalgia syndrome (FMS). Methods. The study comprised 98 female participants (61 newly diagnosed patients and 37 patients under treatment) with FMS, along with 82 apparently healthy female volunteers. In both groups, assessments were conducted using the Fibromyalgia Impact Questionnaire (FIQ), Visual Analogue Scale (VAS), Pittsburgh Sleep Quality Index (PSQI), Fatigue Severity Scale (FSS), Short Form-36 (SF-36), Tender Point Count, Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI). Native thiol (NT) and total thiol (TT) levels were measured, SS levels and SS/NT ratio were calculated. Results. FMS patients demonstrated significantly lower NT levels, higher SS levels, and an elevated SS/NT ratio compared to the control group (p< 0.05 for all groups). In FMS patients, a statistically significant correlation was found between SS level and the SS/NT ratio, as well as the number of tender points (r=-0.24, p=0.02; r=-0.21, p=0.04), SF-36 pain subscales (r=0.22, p=0.032; r=0.21, p=0.04), and BAI scores (r=-0.22, p=0.01; r=-0.23 p=0.03). In the subgroup analysis, all health assessment scales were observed to exhibit statistically significant differences between the under-treatment group and newly-diagnosed group when compared to the control group (p< 0.05 for all groups). The FIQ, VAS, FSS, and BAI scores were found to be significantly lower in the under-treatment group as compared to the newly-diagnosed group (p< 0.05 for all groups). In the newly-diagnosed group, NT was significantly lower and the SS/NT ratio was significantly higher than those in the control group (p< 0.05). In the under-treatment group, SS levels and SS/NT ratio were significantly higher as compared to the control group (p< 0.05). In the multivariate regression analysis, which incorporated age, health assessment scales, patient subgroups, tender points, and duration of symptoms to predict the SS/NT ratio, variabes such as being in the under-treatment group, tender points, and BAI score were identified as significant predictors (p< 0.05). Conclusions. The thiol-SS balance was observed to shift in the oxidative direction, and oxidative stress was higher in the FMS group. The absence of a significant difference between the under-treatment group and the newly-diagnosed group in terms of thiol-SS balance parameters suggests a shift to oxidative stress in patients, independent of the treatment status.

1 June 2026 in Journal of Pediatric Infection
Verified
Journal Article
Closed access
GÇGizem Yılmaz Çalık
Gizem Yılmaz Çalık
STSerçin Taşar
Serçin Taşar
RSRukiye Ünsal Saç
Rukiye Ünsal Saç
EÖElmas Öğüş
Elmas Öğüş
MTMedine Ayşin Taşar
Medine Ayşin Taşar
MŞMehmet Şeneş
Mehmet Şeneş

22 June 2026 in Journal of Pediatric Infection
Verified
Journal Article
Closed access
GÇGizem Yılmaz Çalık
Gizem Yılmaz Çalık
STSerçin Taşar
Serçin Taşar
RSRukiye Ünsal Saç
Rukiye Ünsal Saç
EÖElmas Öğüş
Elmas Öğüş
MTMedine Ayşin Taşar
Medine Ayşin Taşar
MŞMehmet Şeneş
Mehmet Şeneş